Works matching DE "VERTEX Pharmaceuticals Inc."

Results: 44

WORKFLOW'S Towering Aspirations.

Published in:

Bio-IT World, 2010, v. 9, n. 4, p. 30

By:

Russell, John

Publication type:

Article

Predicting Patient Response.

Published in:

Bio-IT World, 2008, v. 7, n. 5, p. 9

By:

Proffitt, Allison

Publication type:

Article

Informatics Black Boxes... Not!

Published in:

2004

By:

Russell, John

Publication type:

Interview

RECOMBINATION.

Published in:: Bio-IT World, 2003, v. 2, n. 9, p. 22
Publication type:: Article

Technology Seems Too Important to Skimp On.

Published in:

Bio-IT World, 2003, v. 2, n. 2, p. 26

By:

Russell, John

Publication type:

Article

US Financial accounts reports.

Published in:

Journal of Commercial Biotechnology, 2002, v. 8, n. 3, p. 262, doi. 10.5912/jcb441

By:

Crocker, Glenn;
Smith, Karen;
Hedley, Clare

Publication type:

Article

First 'breakthrough' drugs designated, but dilution worries linger.

Published in:

Nature Medicine, 2013, v. 19, n. 2, p. 116, doi. 10.1038/nm0213-116

By:

Dolgin, Elie

Publication type:

Article

Two hep C drugs to compete.

Published in:

Chemistry & Industry, 2011, n. 11, p. 11

By:

Dorey, Emma

Publication type:

Article

Pricing for Orphan Drugs.

Published in:

2013

By:

O'Sullivan, Brian P.;
Orenstein, David M.;
Milla, Carlos E.

Publication type:

Opinion

HCV THERAPIES READY TO TIP.

Published in:: Applied Clinical Trials, 2010, v. 19, n. 9, p. 16
Publication type:: Article

Vertex Hepatitis Drug WinsUS Panel Support.

Published in:: Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 107, doi. 10.1093/cid/cir397
Publication type:: Article

Learning from the 2012-2013 class of breakthrough therapies.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 891, doi. 10.1038/nrd4196

By:

Mullard, Asher

Publication type:

Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 91, doi. 10.1038/nrd3947
Publication type:: Article

Excitement mounts for first disease-modifying cystic fibrosis drugs.

Published in:

2011

By:

Opar, Alisa

Publication type:

journal article

Excitement grows for potential revolution in hepatitis C virus treatment.

Published in:

Nature Reviews Drug Discovery, 2010, v. 9, n. 7, p. 501, doi. 10.1038/nrd3214

By:

Opar, Alisa

Publication type:

Article

Competition intensifies around hepatitis C.

Published in:

Nature Biotechnology, 2009, v. 27, n. 4, p. 305, doi. 10.1038/nbt0409-305a

By:

Dorey, Emma

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2009, v. 27, n. 3, p. 296, doi. 10.1038/nbt0309-296
Publication type:: Article

Genomics companies shop around for chemical expertise.

Published in:

Nature Biotechnology, 2004, v. 22, n. 2, p. 137, doi. 10.1038/nbt0204-137

By:

Fletcher, Liz

Publication type:

Article

Aurora throws light on Vertex's aspirations.

Published in:

Nature Biotechnology, 2001, v. 19, n. 6, p. 496, doi. 10.1038/89161

By:

Fletcher, Liz

Publication type:

Article

Research collaborations.

Published in:

Nature Biotechnology, 2001, v. 19, n. 2, p. 98, doi. 10.1038/84503

By:

Bouchie, Aaron

Publication type:

Article

PROTEASE INHIBITOR TRIAL STARTED.

Published in:: AIDS Patient Care & STDs, 1998, v. 12, n. 1, p. 64
Publication type:: Article

Vertex combo scores a broader cystic fibrosis approval.

Published in:

Nature Reviews Drug Discovery, 2015, v. 14, n. 8, p. 517, doi. 10.1038/nrd4704

By:

Mullard, Asher

Publication type:

Article

Telaprevir.

Published in:: Drugs in R&D, 2010, v. 10, n. 3, p. 179, doi. 10.2165/11586020-000000000-00000
Publication type:: Article

Investigational Drug for Hepatitis C Successful in Large Trial.

Published in:

Clinical Infectious Diseases, 2007, v. 44, n. 4, p. iv

By:

Kaye, Donald

Publication type:

Article

HIV/AIDS and STD Updates.

Published in:: AIDS Patient Care & STDs, 2009, v. 23, n. 4, p. 309, doi. 10.1089/apc.2009.9929
Publication type:: Article

HIV/AIDS and STD Updates.

Published in:: AIDS Patient Care & STDs, 2008, v. 22, n. 10, p. 837, doi. 10.1089/apc.2008.9940
Publication type:: Article

Antiviral Briefs.

Published in:: AIDS Patient Care & STDs, 2008, v. 22, n. 4, p. 345, doi. 10.1089/apc.2008.9957
Publication type:: Article

Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.863280

By:

Wang, Yizi;
Ma, Bin;
Li, Wenya;
Li, Peiwen

Publication type:

Article

Modeling & Informatics at Vertex Pharmaceuticals Incorporated: our philosophy for sustained impact.

Published in:

Journal of Computer-Aided Molecular Design, 2017, v. 31, n. 3, p. 293, doi. 10.1007/s10822-016-9994-0

By:

McGaughey, Georgia;
Patrick Walters, W.

Publication type:

Article

GETTING TO KNOW THE FAMILY.

Published in:

Nature, 2002, v. 418, n. 6896, p. 455, doi. 10.1038/418455a

By:

Smith, Adam

Publication type:

Article

Market watch.

Published in:: Nature, 2006, v. 439, n. 7077, p. 659, doi. 10.1038/439659b
Publication type:: Article

Process Analytical Tools for Flow Analysis: A Perspective.

Published in:

Journal of Flow Chemistry, 2017, v. 7, n. 3/4, p. 82, doi. 10.1556/1846.2017.00032

By:

Price, Gregory A.;
Mallik, Debasis;
Organ, Michael G.

Publication type:

Article

A ROUNDUP OF NEWS AND INFORMATION FROM OUR COMMUNITY.

Published in:

CTS: Clinical & Translational Science, 2013, v. 6, n. 2, p. 83, doi. 10.1111/cts.12049

By:

Printz, Carrie

Publication type:

Article

Seven days: 12-18 December 2014.

Published in:: Nature, 2014, v. 516, n. 7531, p. 292, doi. 10.1038/516292a
Publication type:: Article

Drug bests cystic-fibrosis mutation.

Published in:

Nature, 2012, v. 482, n. 7384, p. 145, doi. 10.1038/482145a

By:

Ledford, Heidi

Publication type:

Article

Therapeutics: New drugs hit the target.

Published in:

Nature, 2011, v. 474, n. 7350, p. S5, doi. 10.1038/474S5a

By:

Schlütter, Jana

Publication type:

Article

Breathing easier with combinations.

Published in:

Nature Biotechnology, 2015, v. 33, n. 11, p. 1128, doi. 10.1038/nbt.3397

By:

Azvolinsky, Anna

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2015, v. 33, n. 1, p. 110, doi. 10.1038/nbt.3125
Publication type:: Article

Foundation receives $3.3-billion windfall for Kalydeco.

Published in:

Nature Biotechnology, 2015, v. 33, n. 1, p. 8, doi. 10.1038/nbt0115-8

By:

Senior, Melanie

Publication type:

Article

Vertex buries Incivek.

Published in:: Nature Biotechnology, 2014, v. 32, n. 10, p. 966, doi. 10.1038/nbt1014-966b
Publication type:: Article

Cystic fibrosis combo treatment meets phase 3 endpoints.

Published in:: Nature Biotechnology, 2014, v. 32, n. 8, p. 709, doi. 10.1038/nbt0814-709c
Publication type:: Article

Cystic fibrosis drug Vertex's latest triumph.

Published in:

Nature Biotechnology, 2012, v. 30, n. 3, p. 201, doi. 10.1038/nbt0312-201a

By:

Ledford, Heidi

Publication type:

Article

Hepatitis C: move over interferon.

Published in:

Nature Biotechnology, 2011, v. 29, n. 11, p. 963, doi. 10.1038/nbt.2031

By:

Garber, Ken

Publication type:

Article

The Antidote. Inside the World of New Pharma. By Barry Werth.

Published in:

Angewandte Chemie International Edition, 2014, v. 53, n. 32, p. 8278, doi. 10.1002/anie.201405216

By:

Waldmann, Herbert

Publication type:

Article